TheEdgeResearch
Home / Stocks / SYK

Stryker Corporation (SYK)

NYSE Healthcare Medical - Devices
$273.48 ▼ -0.60%
Market Cap
$104.84B
Sector
Healthcare
Industry
Medical - Devices
Beta
0.77
52-Wk Range
267-392.55
CEO
Kevin A. Lobo
Country
US
Currency
USD

Stryker Corporation operates in the Medical - Devices industry of the Healthcare sector, headquartered in Portage, MI, US. The stock last traded at $273.48, down 0.60% on the session, giving a market capitalisation of $104.84B. On trailing twelve-month figures it carries a trailing P/E of 28.11, a net margin of 14.4%. Its beta of 0.77 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
28.11
Price / Sales
4.06
Price / Book
4.37
EV / EBITDA
18.61
Gross margin
65.2%
Operating margin
22.0%
Net margin
14.4%
Return on equity
Debt / equity
0.62
Current ratio
2.16
Dividend yield
1.3%
Payout ratio
35.3%
Company profile
Exchange
New York Stock Exchange
Employees
56,000
IPO date
1980-03-17
Headquarters
Portage, MI, US
About Stryker Corporation

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

Comparable companies

Stryker Corporation is most often compared with the following Healthcare names:

AMGNBSXDHRGILDHCAMCKMDTPFESNYVRTX
More research on SYK
SYK technical analysis SYK TheEdge Score Compare against peers
Open full interactive analysis & DCF →